No Detail Found!

Clinical laboratory and instrumental peculiarities of atrial fibrillation in obese patients

Author(s)
Ryabaya I.N. Northern State Medical University, 163000, Russia.
Abstract
Considering the conflicting results, which on the one hand revealed an increase in the relapse rates and severity of atrial fibrillation (AF) symptoms in obese patients and on the other hand revealed the reduced mortality risk and cardiovascular events compared to patients with normal body weight and AF, the problem of studying AF peculiarities in obese patients remains relevant. Based on the Federal State Budget Educational Institution of Higher Education "North State Medical University" of the Ministry of Healthcare of the Russian Federation, Arkhangelsk, the research involving 220 patients with AF and AH was carried out. Inclusion criteria were the newly diagnosed AF form and arterial hypertension in past medical history and at the time of inclusion in the study. The aim of the research was to identify AF peculiarities in overweight and obese patients. BMI was calculated, leptin blood concentration was determined, ECHO was made, and AF paroxysms were detected again by means of ECG. The study showed that patients with AF in obese groups had enlarged left ventricular and left atrium and higher incidence of left ventricular hypertrophy than that of the group with normal body weight. The increase in body weight is associated with an increase in the incidence of AF paroxysm relapses. Leptin concentration is significantly higher in the group of patients with paroxysm relapses. Findings: Obesity causes myocardial remodeling progression and an increase in AF paroxysm relapses. Leptin blood concentration is higher in patients with AF paroxysm relapses.
Publication Details
Page(s) 1-6
DOI DOI not available
Published Journal: Archives of Pharmacy Practice, Volume: 11, Issue: 2, Year: 2020

Request the full text from PASTIC

Keywords
Leptin, Obesity, Leptin, paroxysm, atrial fibrillation, structural cardiovascular system indicators
References
Ferrari R,Bertini M,Blomstrom-Lundqvist C,Dobrev D,Kirchhof P,Pappone C . .An update on atrial fibrillation in 2014: From pathophysiology to treatment. International Journal of Cardiology., : .
Stewart S. .2001 .Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart, 86(5) : 516-521.
Veselovskaya Chumakova G.A.,Kozarenko N.G.,A.A. N.G.,Yu Vorobiev .2012 .Peculiarities of heart morphology, structure and function in obesity. Russian cardiological magazine, 4 : 93-99.
.2019 .. lett, 6(1) : 22-37.
Pharm Int. J. .2018 .. Res. Allied Sci, 7(1) : 201-8.
Pharm .2017 .. Educ. Res, 7(3) : 190-3.
Han S,Quon M,Kim J,Koh K.,Adiponectin Cardiovascular,Disease Cardiovascular .2007 .. Journal of the American College of Cardiology, 49(5) : 531-538.
Abed H,Wittert G,Leong D,Shirazi M,Bahrami B,Middeldorp M .2050 .Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation. JAMA, 310(19) : .
Pathak R,Middeldorp M,Meredith M,Mehta A,Mahajan R,Wong C .2015 .Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort. Journal of the American College of Cardiology, 65(20) : 2159-69.
Wyse DG,Waldo AL,DiMarco JP,Domanski MJ,Rosenberg Y,Schron EB .2002 .A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation. New England Journal of Medicine, 347(23) : 1825-33.
Ogawa H,Hamatani Y,Doi K,Tezuka Y,An Y,Ishii M .2017 .SexRelated Differences in the Clinical Events of Patients With Atrial Fibrillation.The Fushimi AF Registry. Circulation Journal, 81(10) : 1403-10.
Marwick T,Gillebert T,Aurigemma G,Chirinos J,Derumeaux G,Galderisi M .2015 .Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). Journal of the American Society of Echocardiography, 28(7) : 727-754.
Stritzke J,Markus M,Duderstadt S,Lieb W,Luchner A,Döring A .2009 .The Aging Process of the Heart: Obesity Is the Main Risk Factor for Left Atrial Enlargement During Aging. Journal of the American College of Cardiology, 54(21) : 1982-89.
Avelar E,Cloward T,Walker J,Farney R,Strong M,Pendleton R .2007 .. Left Ventricular Hypertrophy in Severe Obesity. Hypertension, 49(1) : 34-39.
Wong C,Ganesan A,Selvanayagam J .2016 .Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. European Heart Journal, 38 : 1294-1302.
Lin Y,Chen Y,Chen S Y .2010 .Potential atrial arrhythmogenicity of adipocytes: Implications for the genesis of atrial fibrillation. Medical Hypotheses, 74(6) : 1026-29.
Fukui A,Takahashi N,Masaki T,Kume O,Shinohara T .2013 .Role of Leptin Signaling in the Pathogenesis of Angiotensin IIMediated Atrial Fibrosis and Fibrillation. Circulation: Arrhythmia and Electrophysiology, 6(2) : 402-409.
Ermakov S,Azarbal F,Li LaMonte M,Tharp W,K W .2016 .The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women. Heart, 102(17) : 1354-62.
Tedrow UB,Conen D,Ridker PM,Cook NR,Koplan BA,Manson JE .2010 .The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). J. Am. Coll. Cardiol, 55(21) : 2319-2327.
Tsyplenkova N. S.,Panova E. I.,Zhdankina N. V.,Morozova E.P.,Karatayeva O.V. .2015 .Atrial fibrillation in patients with obesity and arterial hypertension. Internal medicine archive, 5(25) : 62-64.
Goudis CA,Korantzopoulos P,Ntalas IV,Ketikoglou EM,DG EM .2015 .Obesity and atrial fibrillation: A comprehensive review of the pathophysiological mechanisms and links. J. Cardiol, 66(5) : 361-369.
Dedov D. V.,Ivanov A.P.,Elgardt I. A. .2011 .Influence of electromechanical cardiac remodeling on atrial fibrillation development in patients with CAD and arterial hypertension. Russian cardiological magazine, 4(90) : 13-18.
0

Citations

0

Downloads

13

Views